Global Agricultural Biotechnology Market was Valued at USD 33.8 billion by 2024, Observing a CAGR of 10.9% during 2019–2024: VynZ Research NEW YORK, Dec. 17, 2019 (GLOBE NEWSWIRE) -- The global agricultural biotechnology market was valued at USD 33.8 billion in 2018 and is expected to grow at a CAGR of 10.9% during the forecast period....

NapaJen Pharma Announces First Patient Dosed in Phase 1 First-in-Human Clinical Trial of Novel RNA Interference (RNAi) Therapeutic NJA-730 is an Anti-CD-40 Small Interfering RNA (siRNA) Combined with Beta-Glucan Delivery Vehicle with Potential to Treat Acute Graft-versus-Host Disease Program Leverages NapaJen’s Immune...

Streetwise Reports Examines How 'Exciting' Collaborations Possible for Biotech's 'Flexible' Platform SAN FRANCISCO, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Zacks Small-Cap Research's John Vandermosten discussed the potential for this immunotherapy firm's RNAi compounds in oncology. Included in this...

MDRNA Adds June D. Ameen to Management Team as Vice President, Corporate Development BOTHELL, WA--(Marketwire - September 8, 2009) - MDRNA, Inc. (NASDAQ: MRNA) announced today that June D. Ameen, RN, MBA, will join the Company as Vice President, Corporate Development reporting to the...

MDRNA, Inc. Appoints James M. Karis to Its Board of Directors BOTHELL, WA--(Marketwire - August 11, 2009) - MDRNA, Inc. (NASDAQ: MRNA) announced today that James M. Karis has been appointed to the Company's Board of Directors. His appointment brings the number...